Full Industry Chain Purity Control System Pharmaceutical-grade Purity Control
Establish a full-chain purity control system covering raw material cultivation, strain breeding, production processes, and terminal testing, achieving pharmaceutical-grade standards of active substance purity ≥99.5% and total impurities ≤0.02%, exceeding both EU EFSA and US FDA requirements.
Raw Material Interception System
2023 intercepted low-purity materials 41 tons, 3.8% of total procurement
Strain Stability
Growth rate fluctuation 2.3% (initial generation 18%)